-
Get ready for wider availability of the OraQuick HIV-1/2 rapid HIV test: with a June 2004 waiver issued by the Food and Drug Administration (FDA), the test now can be used by more than 180,000 sites in the United States, including outreach clinics, community-based organizations, and physicians offices.
-
Since the extended regimen pill Seasonale (Barr Laboratories, Pomona, NY) hit pharmacy shelves in October 2003, it has become the fourth most-prescribed oral contraceptive in the United States. What do you need to know in counseling women about this new option?
-
Want to drive more men toward your family planning clinic? You may want to consider adding clinic-based vasectomies. The Womens Health Care Clinic at Harbor-University of California Los Angeles (UCLA) Medical Center in Torrance has found success in steering its program in this direction.
-
The 18-year-old patient before you, scheduled for an annual exam, is sexually active and admits that condoms are not always used. What is your next move? If the patient is female, chances are she will be tested for chlamydia, but if the patient is male and asymptomatic, your practice may not include a routine screen for the sexually transmitted disease (STD). New research may have you rethink your approach.
-
The NIH has halted the estrogen-alone wing of the Womens Health Initiative a year before its scheduled end.
-
-
-
Use of antibiotics is associated with increased risk of breast cancer and death from breast cancer in a dose-dependent way.
-
The FDA has approved the first antineoplastic that acts by the inhibiting the formation of new blood vessels in tumors.
-